Fonar Logo
diagnostic imaging management services

* FONAR is not responsible for the accuracy of information on these servers. This link is provided for your convenience only.

 

Fonar Financials Filed with the SEC

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

 

SEC Accession No. 0000355019-20-000007

Filing Date
2020-05-15
Accepted
2020-05-15 15:13:07
Documents
62
Period of Report
2020-03-31
 
Interactive Data
Document Format Files
Seq Description Document Type
1 FONAR CORPORATION 10-Q FOR QUARTER ENDED MARCH 31, 2020 fonar_10-q.htm 10-Q
2 CERTIFICATION fonar_exhibit-31.htm EX-31.1
3 CERTIFICATION fonar_exhibit-32.htm EX-32.1
10 Form 10-Q fonar_logo.jpg GRAPHIC
  Complete submission text file 0000355019-20-000027.txt  

Data Files
Seq Description Document Type
5 XBRL INSTANCE FILE fonr-20200331.xml EX-101.INS
6 XBRL SCHEMA FILE fonr-20200331.xsd EX-101.SCH
7 XBRL CALCULATION FILE fonr-20200331_cal.xml EX-101.CAL
8 XBRL DEFINITION FILE fonr-20200331_def.xml EX-101.DEF
9 XBRL LABEL FILE fonr-20200331_lab.xml EX-101.LAB
10 XBRL PRESENTATION FILE fonr-20200331_pre.xml EX-101.PRE
       

FONAR CORPORATION (Filer) CIK: 0000355019

IRS No.: 112464137 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-10248 | Film No.: 20884356
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
Office of Life Sciences

Business Address

110 Marcus Drive
Melville, NY 11740
631-694-2929
Mailing Address

110 Marcus Drive
Melville, NY 11740